{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:20:13Z","timestamp":1792797613256,"version":"4.5.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T00:00:00Z","timestamp":1375142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T00:00:00Z","timestamp":1375142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/nrcardio.2013.108","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T13:31:14Z","timestamp":1375191074000},"page":"571-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["Genetic testing for inherited cardiac disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Arthur A. M.","family":"Wilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah R.","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,30]]},"reference":[{"key":"BFnrcardio2013108_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","volume":"62","author":"AA Geisterfer-Lowrance","year":"1990","unstructured":"Geisterfer-Lowrance, A. A. et al. A molecular basis for familial hypertrophic cardiomyopathy: a \u03b2 cardiac myosin heavy chain gene missense mutation. Cell 62, 999\u20131006 (1990).","journal-title":"Cell"},{"key":"BFnrcardio2013108_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0092-8674(95)90359-3","volume":"80","author":"Q Wang","year":"1995","unstructured":"Wang, Q. et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80, 805\u2013811 (1995).","journal-title":"Cell"},{"key":"BFnrcardio2013108_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","volume":"80","author":"ME Curran","year":"1995","unstructured":"Curran, M. E. et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80, 795\u2013803 (1995).","journal-title":"Cell"},{"key":"BFnrcardio2013108_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.hrthm.2010.05.036","volume":"7","author":"C van der Werf","year":"2010","unstructured":"van der Werf, C. et al. Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in the Netherlands. Heart Rhythm 7, 1383\u20131389 (2010).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/eurheartj\/ehn219","volume":"29","author":"ER Behr","year":"2008","unstructured":"Behr, E. R. et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur. Heart J. 29, 1670\u20131680 (2008).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013108_CR6","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1016\/j.jacc.2009.12.063","volume":"55","author":"N Hofman","year":"2010","unstructured":"Hofman, N. et al. Active cascade screening in primary inherited arrhythmia syndromes, does it lead to prophylactic treatment? J. Am. Coll. Cardiol. 55, 2570\u20132576 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/01.CIR.88.2.782","volume":"88","author":"PJ Schwartz","year":"1993","unstructured":"Schwartz, P. J., Moss, A. J., Vincent, G. M. & Crampton, R. S. Diagnostic criteria for the long QT syndrome: an update. Circulation 88, 782\u2013784 (1993).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR8","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/humu.21106","volume":"30","author":"PL Hedley","year":"2009","unstructured":"Hedley, P. L. et al. The genetic basis of long QT and short QT syndromes: a mutation update. Hum. Mutat. 30, 1486\u20131511 (2009).","journal-title":"Hum. Mutat."},{"key":"BFnrcardio2013108_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/01.CIR.99.4.529","volume":"99","author":"SG Priori","year":"1999","unstructured":"Priori, S. G., Napolitano, C. & Schwartz, P. J. Low penetrance in the long-QT syndrome: clinical impact. Circulation 99, 529\u2013533 (1999).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/europace\/eur245","volume":"13","author":"MJ Ackerman","year":"2011","unstructured":"Ackerman, M. J. et al. HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13, 1077\u20131109 (2011).","journal-title":"Europace"},{"key":"BFnrcardio2013108_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","volume":"103","author":"PJ Schwartz","year":"2001","unstructured":"Schwartz, P. J. et al. Genotype\u2013phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103, 89\u201395 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR12","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1161\/01.CIR.102.23.2849","volume":"102","author":"L Zhang","year":"2000","unstructured":"Zhang, L. et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 102, 2849\u20132855 (2000).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2006.08.057","volume":"49","author":"AJ Sauer","year":"2007","unstructured":"Sauer, A. J. et al. Long QT syndrome in adults. J. Am. Coll. Cardiol. 49, 329\u2013337 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jacc.2010.07.038","volume":"57","author":"I Goldenberg","year":"2011","unstructured":"Goldenberg, I. et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J. Am. Coll. Cardiol. 57, 51\u201359 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR15","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMoa022147","volume":"348","author":"SG Priori","year":"2003","unstructured":"Priori, S. G. et al. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348, 1866\u20131874 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013108_CR16","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1161\/CIRCULATIONAHA.107.701243","volume":"117","author":"I Goldenberg","year":"2008","unstructured":"Goldenberg, I. et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 117, 2184\u20132191 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jacc.2010.10.025","volume":"57","author":"JF Liu","year":"2011","unstructured":"Liu, J. F. et al. Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome. J. Am. Coll. Cardiol. 57, 941\u2013950 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jacc.2006.09.054","volume":"49","author":"R Seth","year":"2007","unstructured":"Seth, R. et al. Long QT syndrome and pregnancy. J. Am. Coll. Cardiol. 49, 1092\u20131098 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR19","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1161\/CIRCULATIONAHA.106.665406","volume":"115","author":"AJ Moss","year":"2007","unstructured":"Moss, A. J. et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 115, 2481\u20132489 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/hc0702.105124","volume":"105","author":"AJ Moss","year":"2002","unstructured":"Moss, A. J. et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105, 794\u2013799 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR21","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1161\/01.CIR.0000125524.34234.13","volume":"109","author":"P Westenskow","year":"2004","unstructured":"Westenskow, P., Splawski, I., Timothy, K. W., Keating, M. T. & Sanguinetti, M. C. Compound mutations: a common cause of severe long-QT syndrome. Circulation 109, 1834\u20131841 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR22","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.jacc.2009.12.065","volume":"55","author":"M Tomas","year":"2010","unstructured":"Tomas, M. et al. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J. Am. Coll. Cardiol. 55, 2745\u20132752 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR23","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.109.879643","volume":"120","author":"L Crotti","year":"2009","unstructured":"Crotti, L. et al. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation 120, 1657\u20131663 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/eurheartj\/ehr473","volume":"33","author":"AS Amin","year":"2012","unstructured":"Amin, A. S. et al. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur. Heart J. 33, 714\u2013723 (2012).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013108_CR25","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/CIRCULATIONAHA.105.549071","volume":"112","author":"L Crotti","year":"2005","unstructured":"Crotti, L. et al. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation 112, 1251\u20131258 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR26","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1161\/CIRCULATIONAHA.105.562777","volume":"112","author":"DM Roden","year":"2005","unstructured":"Roden, D. M. & Yang, T. Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve. Circulation 112, 1376\u20131378 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR27","unstructured":"CredibleMeds\u2122. Drugs lists by risk groups: Drugs that prolong the QT interval and\/or induce torsades de pointes [online], (2013)."},{"key":"BFnrcardio2013108_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/CIRCEP.109.862649","volume":"2","author":"H Itoh","year":"2009","unstructured":"Itoh, H. et al. Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome. Circ. Arrhythm. Electrophysiol. 2, 511\u2013523 (2009).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2013108_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00109-003-0522-z","volume":"82","author":"AD Paulussen","year":"2004","unstructured":"Paulussen, A. D. et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J. Mol. Med. (Berl.) 82, 182\u2013188 (2004).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrcardio2013108_CR30","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1161\/01.CIR.0000014448.19052.4C","volume":"105","author":"P Yang","year":"2002","unstructured":"Yang, P. et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105, 1943\u20131948 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR31","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1126\/science.1073569","volume":"297","author":"I Splawski","year":"2002","unstructured":"Splawski, I. et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 297, 1333\u20131336 (2002).","journal-title":"Science"},{"key":"BFnrcardio2013108_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCGENETICS.111.960930","volume":"5","author":"S Kaab","year":"2012","unstructured":"Kaab, S. et al. A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ. Cardiovasc. Genet. 5, 91\u201399 (2012).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jacc.2012.03.031","volume":"60","author":"Y Jamshidi","year":"2012","unstructured":"Jamshidi, Y. et al. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J. Am. Coll. Cardiol. 60, 841\u2013850 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1540-8167.2010.01737.x","volume":"21","author":"I Goldenberg","year":"2010","unstructured":"Goldenberg, I. et al. \u03b2-Blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J. Cardiovasc. Electrophysiol. 21, 893\u2013901 (2010).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2013108_CR35","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1161\/CIRCULATIONAHA.111.048041","volume":"125","author":"A Barsheshet","year":"2012","unstructured":"Barsheshet, A. et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta blocker therapy in type 1 long-QT syndrome. Circulation 125, 1988\u20131996 (2012).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR36","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jacc.2003.07.006","volume":"42","author":"SP Etheridge","year":"2003","unstructured":"Etheridge, S. P., Compton, S. J., Tristani-Firouzi, M. & Mason, J. W. A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. J. Am. Coll. Cardiol. 42, 1777\u20131782 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR37","first-page":"2219","volume":"118","author":"N Makita","year":"2008","unstructured":"Makita, N. et al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J. Clin. Invest. 118, 2219\u20132229 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2013108_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10557-012-6433-x","volume":"27","author":"CA Remme","year":"2013","unstructured":"Remme, C. A. & Wilde, A. A. Late sodium current inhibition in acquired and inherited ventricular (dys)function and arrhythmias. Cardiovasc. Drugs Ther. 27, 91\u2013101 (2013).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"BFnrcardio2013108_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/eurheartj\/ehs351","volume":"34","author":"ER Behr","year":"2013","unstructured":"Behr, E. R. & Roden, D. M. Drug-induced arrhythmia: pharmacogenomic prescribing? Eur. Heart J. 34, 89\u201395 (2013).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013108_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","volume":"111","author":"C Antzelevitch","year":"2005","unstructured":"Antzelevitch, C. et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111, 659\u2013670 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR41","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1136\/hrt.2010.201244","volume":"96","author":"M Govindan","year":"2010","unstructured":"Govindan, M. et al. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome. Heart 96, 1904\u20131908 (2010).","journal-title":"Heart"},{"key":"BFnrcardio2013108_CR42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/humu.9144","volume":"21","author":"E Schulze-Bahr","year":"2003","unstructured":"Schulze-Bahr, E. et al. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum. Mutat. 21, 651\u2013652 (2003).","journal-title":"Hum. Mutat."},{"key":"BFnrcardio2013108_CR43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/CIRCEP.111.964577","volume":"5","author":"Y Mizusawa","year":"2012","unstructured":"Mizusawa, Y. & Wilde, A. A. M. Arrhythmogenic disorders of genetic origin: Brugada syndrome. Circ. Arrhythm. Electrophysiol. 5, 606\u2013616 (2012).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2013108_CR44","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1136\/hrt.2011.223883","volume":"97","author":"R Bastiaenen","year":"2011","unstructured":"Bastiaenen, R. & Behr, E. R. Sudden death and ion channel disease: pathophysiology and implications for management. Heart 97, 1365\u20131372 (2011).","journal-title":"Heart"},{"key":"BFnrcardio2013108_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","volume":"7","author":"JD Kapplinger","year":"2010","unstructured":"Kapplinger, J. D. et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 7, 33\u201346 (2010).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR46","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.RES.85.12.1206","volume":"85","author":"C Bezzina","year":"1999","unstructured":"Bezzina, C. et al. A single Na+ channel mutation causing both long-QT and Brugada syndromes. Circ. Res. 85, 1206\u20131213 (1999).","journal-title":"Circ. Res."},{"key":"BFnrcardio2013108_CR47","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","volume":"115","author":"C Antzelevitch","year":"2007","unstructured":"Antzelevitch, C. et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115, 442\u2013449 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR48","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.jacc.2012.04.037","volume":"60","author":"L Crotti","year":"2012","unstructured":"Crotti, L. et al. Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. J. Am. Coll. Cardiol. 60, 1410\u20131418 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR49","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","volume":"2","author":"V Probst","year":"2009","unstructured":"Probst, V. et al. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ. Cardiovasc. Genet. 2, 552\u2013557 (2009).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hrthm.2008.11.009","volume":"6","author":"PG Meregalli","year":"2009","unstructured":"Meregalli, P. G. et al. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm 6, 341\u2013348 (2009).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR51","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","volume":"121","author":"V Probst","year":"2010","unstructured":"Probst, V. et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry. Circulation 121, 635\u2013643 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR52","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1253\/circj.CJ-10-0445","volume":"74","author":"N Nishii","year":"2010","unstructured":"Nishii, N., Ogawa, M. & Morita, H. et al. SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome. Circ. J. 74, 2572\u20132578 (2010).","journal-title":"Circ. J."},{"key":"BFnrcardio2013108_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.105.580811","volume":"113","author":"CR Bezzina","year":"2006","unstructured":"Bezzina, C. R. et al. Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 113, 338\u2013344 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR54","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","volume":"91","author":"A Leenhardt","year":"1995","unstructured":"Leenhardt, A. et al. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 91, 1512\u20131519 (1995).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","volume":"103","author":"SG Priori","year":"2001","unstructured":"Priori, S. G. et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103, 196\u2013200 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR56","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/01.CIR.103.4.485","volume":"103","author":"PJ Laitinen","year":"2001","unstructured":"Laitinen, P. J. et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103, 485\u2013490 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR57","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","volume":"54","author":"A Medeiros-Domingo","year":"2009","unstructured":"Medeiros-Domingo, A. et al. Comprehensive open reading frame mutational analysis of the RYR2-encoded ryanodine receptor\/calcium channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome. J. Am. Coll. Cardiol. 54, 2065\u20132074 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR58","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1086\/324565","volume":"69","author":"H Lahat","year":"2001","unstructured":"Lahat, H. et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am. J. Hum. Genet. 69, 1378\u20131384 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR59","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.hrthm.2009.06.033","volume":"6","author":"M Cerrone","year":"2009","unstructured":"Cerrone, M., Napolitano, C. & Priori, S. G. Catecholaminergic polymorphic ventricular tachycardia: a paradigm to understand mechanisms of arrhythmias associated to impaired Ca2+ regulation. Heart Rhythm 6, 1652\u20131659 (2009).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR60","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ajhg.2012.08.015","volume":"91","author":"M Nyegaard","year":"2012","unstructured":"Nyegaard, M. et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am. J. Hum. Genet. 91, 703\u2013712 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR61","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1093\/hmg\/dds104","volume":"21","author":"N Roux-Buisson","year":"2012","unstructured":"Roux-Buisson, N. et al. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human. Hum. Mol. Genet. 21, 2759\u20132767 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrcardio2013108_CR62","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.hrthm.2006.03.025","volume":"3","author":"DJ Tester","year":"2006","unstructured":"Tester, D. J. et al. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing. Heart Rhythm 3, 800\u2013805 (2006).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","volume":"106","author":"SG Priori","year":"2002","unstructured":"Priori, S. G. et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106, 69\u201374 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR64","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","volume":"119","author":"M Hayashi","year":"2009","unstructured":"Hayashi, M. et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 119, 2426\u20132434 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR65","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","volume":"5","author":"C van der Werf","year":"2012","unstructured":"van der Werf, C. et al. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives. Circ. Arrhythm. Electrophysiol. 5, 748\u2013756 (2012).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2013108_CR66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","volume":"109","author":"R Brugada","year":"2004","unstructured":"Brugada, R. et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109, 30\u201335 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR67","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1161\/01.CIR.0000130409.72142.FE","volume":"109","author":"C Bellocq","year":"2004","unstructured":"Bellocq, C. et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109, 2394\u20132397 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR68","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/01.RES.0000162101.76263.8c","volume":"96","author":"SG Priori","year":"2005","unstructured":"Priori, S. G. et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ. Res. 96, 800\u2013807 (2005).","journal-title":"Circ. Res."},{"key":"BFnrcardio2013108_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1540-8167.2008.01326.x","volume":"20","author":"M Ha\u00efssaguerre","year":"2009","unstructured":"Ha\u00efssaguerre, M. et al. Ventricular fibrillation with prominent early repolarization changes associated to a rare variant of KCNJ8\/KATP channel. J. Cardiovasc. Electrophysiol. 20, 93\u201398 (2009).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2013108_CR70","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCEP.111.963983","volume":"4","author":"H Watanabe","year":"2011","unstructured":"Watanabe, H. et al. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. Circ. Arrhythm. Electrophysiol. 4, 874\u2013881 (2011).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2013108_CR71","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.hrthm.2010.08.026","volume":"7","author":"E Burashnikov","year":"2010","unstructured":"Burashnikov, E. et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 7, 1872\u20131882 (2010).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR72","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1172\/JCI38292","volume":"119","author":"M Kruse","year":"2009","unstructured":"Kruse, M. et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J. Clin. Invest. 119, 2737\u20132744 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2013108_CR73","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/12618","volume":"23","author":"JJ Schott","year":"1999","unstructured":"Schott, J. J. et al. Cardiac conduction defects associate with mutations in SCN5A. Nat. Genet. 23, 20\u201321 (1999).","journal-title":"Nat. Genet."},{"key":"BFnrcardio2013108_CR74","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ajhg.2009.02.009","volume":"84","author":"M Alders","year":"2009","unstructured":"Alders, M. et al. Haplotype sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation. Am. J. Hum. Genet. 84, 468\u2013476 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR75","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1126\/science.1077771","volume":"299","author":"YH Chen","year":"2003","unstructured":"Chen, Y. H. et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299, 251\u2013254 (2003).","journal-title":"Science"},{"key":"BFnrcardio2013108_CR76","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1086\/425342","volume":"75","author":"Y Yang","year":"2004","unstructured":"Yang, Y. et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am. J. Hum. Genet. 75, 899\u2013905 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR77","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.bbrc.2005.05.054","volume":"332","author":"M Xia","year":"2005","unstructured":"Xia, M. et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem. Biophys. Res. Commun. 332, 1012\u20131019 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrcardio2013108_CR78","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.hrthm.2010.09.010","volume":"8","author":"DC Bartos","year":"2011","unstructured":"Bartos, D. C. et al. R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation. Heart Rhythm 8, 48\u201355 (2011).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR79","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1172\/JCI200316387","volume":"111","author":"E Schulze-Bahr","year":"2003","unstructured":"Schulze-Bahr, E. et al. Pacemaker channel dysfunction in a patient with sinus node disease. J. Clin. Invest. 111, 1537\u20131545 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2013108_CR80","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1172\/JCI200318062","volume":"112","author":"DW Benson","year":"2003","unstructured":"Benson, D. W. et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Invest. 112, 1019\u20131028 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2013108_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jacc.2012.02.052","volume":"60","author":"G Laurent","year":"2012","unstructured":"Laurent, G. et al. Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy. J. Am. Coll. Cardiol. 60, 144\u2013156 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR82","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-pathol-011110-130151","volume":"6","author":"JE Saffitz","year":"2011","unstructured":"Saffitz, J. E. The pathobiology of arrhythmogenic cardiomyopathy. Annu. Rev. Pathol. 6, 299\u2013321 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"BFnrcardio2013108_CR83","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"BJ Gersch","year":"2011","unstructured":"Gersch, B. J. et al. ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 58, e212\u2013e260 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR84","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/eurheartj\/ehr092","volume":"32","author":"I Christiaans","year":"2011","unstructured":"Christiaans, I. et al. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. Eur. Heart J. 32, 1161\u20131170 (2011).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013108_CR85","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/europace\/eup431","volume":"12","author":"I Christiaans","year":"2010","unstructured":"Christiaans, I. et al. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. Europace 12, 313\u2013321 (2010).","journal-title":"Europace"},{"key":"BFnrcardio2013108_CR86","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1172\/JCI116038","volume":"90","author":"H Watkins","year":"1992","unstructured":"Watkins, H., Thierfelder, L. & Hwang, D. S. et al. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J. Clin. Invest. 90, 1666\u20131671 (1992).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2013108_CR87","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","volume":"332","author":"H Watkins","year":"1995","unstructured":"Watkins, H. et al. Mutations in the genes for cardiac troponin T and \u03b1-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332, 1058\u20131064 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013108_CR88","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJM199204233261703","volume":"326","author":"H Watkins","year":"1992","unstructured":"Watkins, H. et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 326, 1108\u20131114 (1992).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013108_CR89","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1161\/hc3701.095952","volume":"104","author":"AM Varnava","year":"2001","unstructured":"Varnava, A. M. et al. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104, 1380\u20131384 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/CIRCGENETICS.111.959973","volume":"5","author":"F Pasquale","year":"2012","unstructured":"Pasquale, F. et al. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene. Circ. Cardiovasc. Genet. 5, 10\u201317 (2012).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR91","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","volume":"107","author":"P Richard","year":"2003","unstructured":"Richard, P. et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107, 2227\u20132232 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR92","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0025-6196(11)61527-9","volume":"80","author":"SL Van Driest","year":"2005","unstructured":"Van Driest, S. L., Ommen, S. R., Tajik, A. J., Gersh, B. J. & Ackerman, M. J. Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clin. Proc. 80, 739\u2013744 (2005).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrcardio2013108_CR93","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/euhj.1998.1145","volume":"20","author":"L Mestroni","year":"1999","unstructured":"Mestroni, L. et al. Guidelines for the study of familial dilated cardiomyopathies: collaborative research group of the European Human and Capital Mobility Project on familial dilated cardiomyopathy. Eur. Heart J. 20, 93\u2013102 (1999).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013108_CR94","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/eurjhf\/hft013","volume":"15","author":"KY van Spaendonck-Zwarts","year":"2013","unstructured":"van Spaendonck-Zwarts, K. Y. et al. Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience. Eur. J. Heart Fail. 15, 628\u2013636 (2013).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrcardio2013108_CR95","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman, D. S. et al. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366, 619\u2013628 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2013108_CR96","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","volume":"59","author":"IA van Rijsingen","year":"2012","unstructured":"van Rijsingen, I. A. et al. Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study. J. Am. Coll. Cardiol. 59, 493\u2013500 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR97","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/CIRCEP.111.962035","volume":"5","author":"C Basso","year":"2012","unstructured":"Basso, C., Corrado, D., Bauce, B. & Thiene, G. Arrhythmogenic right ventricular cardiomyopathy. Circ. Arrhythm. Electrophysiol. 5, 1233\u20131246 (2012).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2013108_CR98","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.jacc.2010.12.036","volume":"57","author":"JD Kapplinger","year":"2011","unstructured":"Kapplinger, J. D. et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy\/dysplasia-associated mutations from background genetic noise. J. Am. Coll. Cardiol. 57, 2317\u20132327 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR99","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jmb.2011.06.047","volume":"411","author":"C Al-Jassar","year":"2011","unstructured":"Al-Jassar, C. et al. The nonlinear structure of the desmoplakin plakin domain and the effects of cardiomyopathy-linked mutations. J. Mol. Biol. 411, 1049\u20131061 (2011).","journal-title":"J. Mol. Biol."},{"key":"BFnrcardio2013108_CR100","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1161\/CIRCULATIONAHA.110.976936","volume":"123","author":"G Quarta","year":"2011","unstructured":"Quarta, G. et al. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation 123, 2701\u20132709 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR101","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1161\/CIRCULATIONAHA.110.988287","volume":"123","author":"MG Cox","year":"2011","unstructured":"Cox, M. G. et al. Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy Genotype\u2013Phenotype Follow-up Study. Circulation 123, 2690\u20132700 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR102","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.hrthm.2011.07.034","volume":"9","author":"C Semsarian","year":"2012","unstructured":"Semsarian, C. & Hamilton, R. M. Key role of the molecular autopsy in sudden unexpected death. Heart Rhythm 9, 145\u2013150 (2012).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR103","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/HCO.0b013e32835b0a9e","volume":"28","author":"H Raju","year":"2013","unstructured":"Raju, H. & Behr, E. R. Unexplained sudden death, focussing on genetics and family phenotyping. Curr. Opin. Cardiol. 28, 19\u201325 (2013).","journal-title":"Curr. Opin. Cardiol."},{"key":"BFnrcardio2013108_CR104","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/CIRCGENETICS.112.963785","volume":"5","author":"JR Giudicessi","year":"2012","unstructured":"Giudicessi, J. R. et al. Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome. Circ. Cardiovasc. Genet. 5, 519\u2013528 (2012).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR105","doi-asserted-by":"publisher","unstructured":"Andreasen, C. et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur. J. Hum. Genet. http:\/\/dx.doi.org\/10.1038\/ejhg.2012.283.","DOI":"10.1038\/ejhg.2012.283"},{"key":"BFnrcardio2013108_CR106","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/ejhg.2012.23","volume":"20","author":"L Refsgaard","year":"2012","unstructured":"Refsgaard, L. et al. High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur. J. Hum. Genet. 20, 905\u2013908 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR107","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.hrthm.2011.07.017","volume":"8","author":"J Ingles","year":"2011","unstructured":"Ingles, J. et al. The emerging role of the cardiac genetic counselor. Heart Rhythm 8, 1958\u20131962 (2011).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR108","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCGENETICS.109.912345","volume":"3","author":"RE Hershberger","year":"2010","unstructured":"Hershberger, R. E. et al. Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ. Cardiovasc. Genet. 3, 155\u2013161 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR109","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCEP.110.959619","volume":"4","author":"S Ohno","year":"2011","unstructured":"Ohno, S. et al. KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation. Circ. Arrhythm. Electrophysiol. 4, 352\u2013361 (2011).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2013108_CR110","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/jce.12068","volume":"24","author":"DC Bartos","year":"2012","unstructured":"Bartos, D. C. et al. A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation. J. Cardiovasc. Electrophysiol. 24, 562\u2013569 (2012).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio2013108_CR111","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ajhg.2010.04.017","volume":"86","author":"Y Yang","year":"2010","unstructured":"Yang, Y. et al. Identification of a Kir3.4 mutation in congenital long QT syndrome. Am. J. Hum. Genet. 86, 872\u2013880 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR112","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.hrthm.2010.06.016","volume":"7","author":"A Medeiros-Domingo","year":"2010","unstructured":"Medeiros-Domingo, A. et al. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac KATP channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm 7, 1466\u20131471 (2010).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio2013108_CR113","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/ng1329","volume":"36","author":"M Bienengraeber","year":"2004","unstructured":"Bienengraeber, M. et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat. Genet. 36, 382\u2013387 (2004).","journal-title":"Nat. Genet."},{"key":"BFnrcardio2013108_CR114","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbrc.2003.11.101","volume":"313","author":"T Hayashi","year":"2004","unstructured":"Hayashi, T. et al. Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 313, 178\u2013184 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrcardio2013108_CR115","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/CIRCEP.111.969972","volume":"5","author":"T Ishikawa","year":"2012","unstructured":"Ishikawa, T. et al. A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. Circ. Arrhythm. Electrophysiol. 5, 1098\u20131107 (2012).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio2013108_CR116","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1529\/biophysj.107.122382","volume":"94","author":"A Koop","year":"2008","unstructured":"Koop, A., Goldmann, P., Chen, S. R. W., Thieleczek, R. & Vars\u00e1nyi, M. ARVC-related mutations in divergent region 3 alter functional properties of the cardiac ryanodine receptor. Biophys. J. 94, 4668\u20134677 (2008).","journal-title":"Biophys. J."},{"key":"BFnrcardio2013108_CR117","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.112.001216","volume":"127","author":"L Crotti","year":"2013","unstructured":"Crotti, L. et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation 127, 1009\u20131017 (2013).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR118","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.yjmcc.2007.04.006","volume":"42","author":"AP Landstrom","year":"2007","unstructured":"Landstrom, A. P. et al. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J. Mol. Cell. Cardiol. 42, 1026\u20131035 (2007).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio2013108_CR119","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ahj.2010.08.001","volume":"161","author":"AP Landstrom","year":"2011","unstructured":"Landstrom, A. P., Adekola, B. A., Bos, J. M., Ommen, S. R. & Ackerman, M. J. PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing. Am. Heart J. 161, 165\u2013171 (2011).","journal-title":"Am. Heart J."},{"key":"BFnrcardio2013108_CR120","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","volume":"14","author":"PA van der Zwaag","year":"2012","unstructured":"van der Zwaag, P. A. et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur. J. Heart Fail. 14, 1199\u20131207 (2012).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrcardio2013108_CR121","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1086\/509900","volume":"79","author":"D Li","year":"2006","unstructured":"Li, D. et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am. J. Hum. Genet. 79, 1030\u20131039 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR122","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/156652412800620020","volume":"12","author":"AP Landstrom","year":"2012","unstructured":"Landstrom, A. P. & Ackerman, M. J. Beyond the cardiac myofilament: hypertrophic cardiomyopathy-associated mutations in genes that encode calcium-handling proteins. Curr. Mol. Med. 12, 507\u2013518 (2012).","journal-title":"Curr. Mol. Med."},{"key":"BFnrcardio2013108_CR123","doi-asserted-by":"publisher","first-page":"e54131","DOI":"10.1371\/journal.pone.0054131","volume":"8","author":"H Liu","year":"2013","unstructured":"Liu, H. et al. Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel. PLoS ONE 8, e54131 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2013108_CR124","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/jhg.2008.16","volume":"54","author":"K Ueda","year":"2009","unstructured":"Ueda, K. et al. Role of HCN4 channel in preventing ventricular arrhythmia. J. Hum. Genet. 54, 115\u2013121 (2009).","journal-title":"J. Hum. Genet."},{"key":"BFnrcardio2013108_CR125","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00109-005-0635-7","volume":"83","author":"A Perrot","year":"2005","unstructured":"Perrot, A. et al. Prevalence of cardiac \u03b2-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Mol. Med. (Berl.) 83, 468\u2013477 (2005).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrcardio2013108_CR126","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/CIRCGENETICS.108.821314","volume":"2","author":"JP Kaski","year":"2009","unstructured":"Kaski, J. P. et al. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ. Cardiovasc. Genet. 2, 436\u2013441 (2009).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR127","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/eurheartj\/ehi193","volume":"26","author":"E Villard","year":"2005","unstructured":"Villard, E. et al. Mutation screening in dilated cardiomyopathy: prominent role of the \u03b2 myosin heavy chain gene. Eur. Heart J. 26, 794\u2013803 (2005).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013108_CR128","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.104.507699","volume":"112","author":"E Carniel","year":"2005","unstructured":"Carniel, E. et al. \u03b1-Myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 112, 54\u201359 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR129","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/01.CIR.103.1.65","volume":"103","author":"A Karibe","year":"2001","unstructured":"Karibe, A. et al. Hypertrophic cardiomyopathy caused by a novel \u03b1-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 103, 65\u201371 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR130","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/01.CIR.91.9.2302","volume":"91","author":"H Watkins","year":"1995","unstructured":"Watkins, H. et al. A de novo mutation in \u03b1-tropomyosin that causes hypertrophic cardiomyopathy. Circulation 91, 2302\u20132305 (1995).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR131","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ymgme.2005.08.006","volume":"87","author":"VC Vasile","year":"2006","unstructured":"Vasile, V. C. et al. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol. Genet. Metab. 87, 169\u2013174 (2006).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrcardio2013108_CR132","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1093\/hmg\/ddn160","volume":"17","author":"C Geier","year":"2008","unstructured":"Geier, C. et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum. Mol. Genet. 17, 2753\u20132765 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrcardio2013108_CR133","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.jacc.2004.08.058","volume":"44","author":"T Hayashi","year":"2004","unstructured":"Hayashi, T. et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44, 2192\u20132201 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR134","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/eurheartj\/ehp225","volume":"30","author":"L Duboscq-Bidot","year":"2009","unstructured":"Duboscq-Bidot, L. et al. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur. Heart J. 30, 2128\u20132136 (2009).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013108_CR135","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/cvr\/cvm015","volume":"77","author":"L Duboscq-Bidot","year":"2008","unstructured":"Duboscq-Bidot, L. et al. Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. Cardiovasc. Res. 77, 118\u2013125 (2008).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2013108_CR136","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1096-7192(03)00142-2","volume":"80","author":"B Mohapatra","year":"2003","unstructured":"Mohapatra, B. et al. Mutations in the muscle LIM protein and \u03b1-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol. Genet. Metab. 80, 207\u2013215 (2003).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrcardio2013108_CR137","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jacc.2009.11.016","volume":"55","author":"C Chiu","year":"2010","unstructured":"Chiu, C. et al. Mutations in \u03b1-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis. J. Am. Coll. Cardiol. 55, 1127\u20131135 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2013108_CR138","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1161\/01.RES.0000263008.66799.aa","volume":"100","author":"A Osio","year":"2007","unstructured":"Osio, A. et al. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ. Res. 100, 766\u2013768 (2007).","journal-title":"Circ. Res."},{"key":"BFnrcardio2013108_CR139","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/cvr\/cvs294","volume":"97","author":"A Ruggiero","year":"2013","unstructured":"Ruggiero, A., Chen, S. N., Lombardi, R., Rodriguez, G. & Marian, A. J. Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity. Cardiovasc. Res. 97, 44\u201354 (2013).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2013108_CR140","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/nm.2037","volume":"15","author":"D Hassel","year":"2009","unstructured":"Hassel, D. et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat. Med. 15, 1281\u20131288 (2009).","journal-title":"Nat. Med."},{"key":"BFnrcardio2013108_CR141","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ajhg.2010.10.002","volume":"87","author":"H Wang","year":"2010","unstructured":"Wang, H. et al. Mutations in NEXN, a Z-disc gene, are associated with hypertrophic cardiomyopathy. Am. J. Hum. Genet. 87, 687\u2013693 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR142","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.bbrc.2006.05.203","volume":"346","author":"A Pilotto","year":"2006","unstructured":"Pilotto, A. et al. \u03b1B-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands. Biochem. Biophys. Res. Comm. 346, 1115\u20131117 (2006).","journal-title":"Biochem. Biophys. Res. Comm."},{"issue":"Suppl. II","key":"BFnrcardio2013108_CR143","first-page":"340","volume":"116","author":"CS Sriram","year":"2007","unstructured":"Sriram, C. S., Bos, J. M., Ommen, S. R. & Ackerman, M. J. Mutational analysis of CRYAB-encoded crystallin \u03b1B in hypertrophic cardiomyopathy [abstract 1625]. Circulation 116 (Suppl. II) 340 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR144","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0960-8966(99)00015-2","volume":"9","author":"A Ferlini","year":"1999","unstructured":"Ferlini, A., Sewry, C., Melis, M. A., Mateddu, A. & Muntoni, F. X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul. Disord. 9, 339\u2013346 (1999).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrcardio2013108_CR145","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/hmg\/dds556","volume":"22","author":"H-F Tse","year":"2013","unstructured":"Tse, H.-F. et al. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum. Mol. Genet 22, 1395\u20131403 (2013).","journal-title":"Hum. Mol. Genet"},{"key":"BFnrcardio2013108_CR146","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ymgme.2006.12.008","volume":"90","author":"AM Arola","year":"2007","unstructured":"Arola, A. M. et al. Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy. Mol. Genet. Metab. 90, 435\u2013440 (2007).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrcardio2013108_CR147","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/jmg.32.8.654","volume":"32","author":"S Manouvrier","year":"1995","unstructured":"Manouvrier, S. et al. Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. J. Med. Genet. 32, 654\u2013656 (1995).","journal-title":"J. Med. Genet."},{"key":"BFnrcardio2013108_CR148","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.nmd.2005.02.004","volume":"15","author":"T M\u00fcller","year":"2005","unstructured":"M\u00fcller, T., Krasnianski, M., Witthaut, R., Deschauer, M. & Zierz, S. Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation. Neuromuscul. Disord. 15, 372\u2013376 (2005).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrcardio2013108_CR149","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.107.689984","volume":"116","author":"R Kn\u00f6ll","year":"2007","unstructured":"Kn\u00f6ll, R. et al. Laminin-\u03b14 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation 116, 515\u2013525 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio2013108_CR150","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1253\/circj.CJ-08-0722","volume":"73","author":"T Arimura","year":"2009","unstructured":"Arimura, T. et al. Mutational analysis of fukutin gene in dilated cardiomyopathy and hypertrophic cardiomyopathy. Circ. J. 73, 158\u2013161 (2009).","journal-title":"Circ. J."},{"key":"BFnrcardio2013108_CR151","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0883073812448535","volume":"27","author":"RM Payne","year":"2012","unstructured":"Payne, R. M. & Wagner, G. R. Cardiomyopathy in Friedreich ataxia: clinical findings and research. J. Child Neurol. 27, 1179\u20131186 (2012).","journal-title":"J. Child Neurol."},{"key":"BFnrcardio2013108_CR152","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1172\/JCI9224","volume":"106","author":"S Tsubata","year":"2000","unstructured":"Tsubata, S. et al. Mutations in the human \u03b4-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J. Clin. Invest. 106, 655\u2013662 (2000).","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 1","key":"BFnrcardio2013108_CR153","first-page":"135","volume":"101","author":"A Erhardt","year":"2006","unstructured":"Erhardt, A. et al. HFE mutations in idiopathic dilated cardiomyopathy. Med. Klin. (Munich) 101 (Suppl. 1), 135\u2013138 (2006).","journal-title":"Med. Klin. (Munich)"},{"key":"BFnrcardio2013108_CR154","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1399-0004.2012.01919.x","volume":"83","author":"K Hodgkinson","year":"2013","unstructured":"Hodgkinson, K. et al. The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43. Clin. Genet. 83, 321\u2013331 (2013).","journal-title":"Clin. Genet."},{"key":"BFnrcardio2013108_CR155","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/jama.2009.371","volume":"301","author":"BJ Maron","year":"2009","unstructured":"Maron, B. J. et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA 301, 1253\u20131259 (2009).","journal-title":"JAMA"},{"key":"BFnrcardio2013108_CR156","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/eurjhf\/hfq073","volume":"12","author":"O Havndrup","year":"2010","unstructured":"Havndrup, O. et al. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur. J. Heart Fail. 12, 535\u2013540 (2010).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrcardio2013108_CR157","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s00246-009-9521-3","volume":"30","author":"BP Kelly","year":"2009","unstructured":"Kelly, B. P., Russell, M. W., Hennessy, J. R. & Ensing, G. J. Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation. Pediat. Cardiol. 30, 1176\u20131179 (2009).","journal-title":"Pediat. Cardiol."},{"key":"BFnrcardio2013108_CR158","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.recesp.2012.09.017","volume":"6","author":"A Carcavilla","year":"2013","unstructured":"Carcavilla, A. et al. LEOPARD syndrome: a variant of Noonan syndrome strongly associated with hypertrophic cardiomyopathy. Rev. Esp. Cardiol. 6, 350\u2013356 (2013).","journal-title":"Rev. Esp. Cardiol."},{"key":"BFnrcardio2013108_CR159","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","volume":"39","author":"B Pandit","year":"2007","unstructured":"Pandit, B. et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat. Genet. 39, 1007\u20131012 (2007).","journal-title":"Nat. Genet."},{"key":"BFnrcardio2013108_CR160","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0092-8674(01)00586-4","volume":"107","author":"JS Davis","year":"2001","unstructured":"Davis, J. S. et al. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell 107, 631\u2013641 (2001).","journal-title":"Cell"},{"key":"BFnrcardio2013108_CR161","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","volume":"15","author":"RE Hershberger","year":"2009","unstructured":"Hershberger, R. E. et al. Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America practice guideline. J. Card. Fail. 15, 83\u201397 (2009).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio2013108_CR162","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1093\/hmg\/9.18.2761","volume":"9","author":"EE Norgett","year":"2000","unstructured":"Norgett, E. E. et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum. Mol. Genet. 9, 2761\u20132766 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrcardio2013108_CR163","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCGENETICS.110.937805","volume":"3","author":"P Elliott","year":"2010","unstructured":"Elliott, P. et al. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ. Cardiovasc. Genet. 3, 314\u2013322 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR164","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/hmg\/dds157","volume":"21","author":"FW Friedrich","year":"2012","unstructured":"Friedrich, F. W. et al. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum. Mol. Genet. 21, 3237\u20133254 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrcardio2013108_CR165","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/CIRCGENETICS.111.962332","volume":"5","author":"JS Binder","year":"2012","unstructured":"Binder, J. S. et al. Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene. Circ. Cardiovasc. Genet. 5, 490\u2013502 (2012).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR166","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2007.03.128","volume":"357","author":"T Arimura","year":"2007","unstructured":"Arimura, T. et al. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 357, 162\u2013167 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrcardio2013108_CR167","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2350-8-65","volume":"8","author":"G Beffagna","year":"2007","unstructured":"Beffagna, G. et al. Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. BMC Med. Genet. 8, 65 (2007).","journal-title":"BMC Med. Genet."},{"key":"BFnrcardio2013108_CR168","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ng0496-385","volume":"12","author":"S Bione","year":"1996","unstructured":"Bione, S. et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat. Genet. 12, 385\u2013389 (1996).","journal-title":"Nat. Genet."},{"key":"BFnrcardio2013108_CR169","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/S0002-9440(10)65738-0","volume":"153","author":"E Arbustini","year":"1998","unstructured":"Arbustini, E. et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am. J. Pathol. 153, 1501\u20131510 (1998).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio2013108_CR170","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ejhg.2010.83","volume":"18","author":"A Levitas","year":"2010","unstructured":"Levitas, A. et al. Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase. Eur. J. Hum. Genet. 18, 1160\u20131165 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrcardio2013108_CR171","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nm.2693","volume":"18","author":"W Guo","year":"2012","unstructured":"Guo, W. et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat. Med. 18, 766\u2013773 (2012).","journal-title":"Nat. Med."},{"key":"BFnrcardio2013108_CR172","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/eurheartj\/ehr451","volume":"33","author":"G Quarta","year":"2012","unstructured":"Quarta, G. et al. Mutations in the lamin A\/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 33, 1128\u20131136 (2012).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2013108_CR173","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/humu.20250","volume":"26","author":"MRG Taylor","year":"2005","unstructured":"Taylor, M. R. G. et al. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum. Mut. 26, 566\u2013574 (2005).","journal-title":"Hum. Mut."},{"key":"BFnrcardio2013108_CR174","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCGENETICS.111.961052","volume":"4","author":"JL Theis","year":"2011","unstructured":"Theis, J. L. et al. Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy. Circ. Cardiovasc. Genet. 4, 585\u2013594 (2011).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrcardio2013108_CR175","doi-asserted-by":"publisher","first-page":"e1002427","DOI":"10.1371\/journal.pgen.1002427","volume":"7","author":"DJ Lefeber","year":"2011","unstructured":"Lefeber, D. J. et al. Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet. 7, e1002427 (2011).","journal-title":"PLoS Genet."},{"key":"BFnrcardio2013108_CR176","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cardiores.2004.10.005","volume":"65","author":"G Beffagna","year":"2005","unstructured":"Beffagna, G. et al. Regulatory mutations in transforming growth factor-\u03b23 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc. Res. 65, 366\u2013373 (2005).","journal-title":"Cardiovasc. Res."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2013.108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2013.108","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2013.108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T17:59:31Z","timestamp":1715795971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2013.108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,30]]},"references-count":176,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["BFnrcardio2013108"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2013.108","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,30]]},"assertion":[{"value":"30 July 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A. A. M. Wilde declares that he is a member of the advisory board of Sorin. E. R. Behr declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}